Moreover, YTHDC2 modulated LUAD development by regulating the levels of cell division cycle-related protein CDCA4, thereby inhibiting the malignant phenotype and altering the M1/M2 cell ratio in tumor tissue [44]. Here, YTHDC2 is linked to neoplasm.